Rena-Vite Tablets By Cypress Pharmaceutical Overview & Drug Interactions

Check For Interactions With Rena-Vite Tablets

Supplement: Rena-Vite Tablets by Cypress Pharmaceutical

Rena-Vite Tablets Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Rena-Vite Tablets by Cypress Pharmaceutical

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Tablet(s)
Maximum serving Sizes:
1 Tablet(s)
Servings per container 100
UPC/BARCODE 360258160018

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Vitamin C
60 mg
Vitamin C 67%
Vitamin B1
1.5 mg
Thiamin 125%
Vitamin B2
1.7 mg
Riboflavin 131%
Niacinamide
20 mg
Niacin 125%
Vitamin B6
10 mg
Vitamin B6 588%
Folate
1333 mcg DFE
Folate 333%
Folic Acid
800 mcg
Folate
Vitamin B12
6 mcg
Vitamin B12 250%
Biotin
300 mcg
Biotin 1000%
Pantothenic Acid
10 mg
Pantothenic Acid 200%

Other Ingredients:
Dicalcium Phosphate
Microcrystalline Cellulose
Croscarmellose Sodium
Stearic Acid
Hypromellose
Magnesium Stearate
Talc
FD&C Red #40
Polyethylene Glycol
Mineral Oil
FD&C Yellow #6
Titanium Dioxide


Label Statments:


General
- Product Code 60258-160-01
FDA Statement of Identity
- Dietary Supplement
Precautions
- Do not use if imprinted safety seal under cap is broken or missing.
- Warning: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B-12 is deficient. Precautions: Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using this product since folic acid may mask the symptoms of pernicious anemia.
- Adverse reactions: Allergic sensitization has been reported following both oral and paranteral administration of folic acid.
- Keep this product out of the reach of children. In case of accidental overdose, seek professional assistance or contact a poison control center imeediately.
- You should call your doctor for medical advice about serious adverse events. To report a serious adverse event or obtain product information, contact Cypress Pharmaceutical, Inc. at 1-800-793-2145 or FDA at 1-800-FDA-1088 (Toll free).
Suggested/Recommended/Usage/Directions
- Directions: One tablet daily or as directed by a physician.
Storage
- Storage: Store at controlled room temperature 15 degrees - 30 degrees C (59 degrees - 86 degrees F). [See USP]. Protect from light and moisture. Dispense in a tight, light-resistant container.
General Statements
- The numeric identifier on this product's labeling is an assigned product code for use with pharmacy-level, health-insurance and state level reimbursement programs and is not intended to denote registration with the FDA.
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Brand Information

See all products by this brand

Manufactured for
Name Cypress Pharmaceutical, Inc.
City Morristown
State NJ
ZipCode 07960
Phone Number 1-800-793-2145

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.